[unable to retrieve full-text content]
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
[unable to retrieve full-text content]
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Omnixia News is your intelligent news aggregator, delivering real-time, curated headlines from trusted global sources. Stay informed with personalized updates on tech, business, entertainment, and more — all in one place..